Skip to content

Charlie Lee appointment

MEI Pharma Shifts to Litecoin Treasury Strategy with $100M Funding, Appoints Litecoin Founder Charlie Lee to Board

MEI Pharma has announced a strategic pivot to become a Litecoin-focused treasury company after raising $100 million through a private placement. The funding involved issuing 29,239,767 shares at $3.42 per share, marking a decisive shift from its pharmaceutical origins. Litecoin… Read More »MEI Pharma Shifts to Litecoin Treasury Strategy with $100M Funding, Appoints Litecoin Founder Charlie Lee to Board

MEI Pharma Allocates $100 Million to Litecoin Reserves, Appoints Creator Charlie Lee to Board

Biopharmaceutical firm MEI Pharma has executed a $100 million private placement to acquire Litecoin (LTC) as a reserve asset, issuing approximately 29.24 million shares at $3.42 each. This strategic allocation marks a significant corporate treasury shift toward blockchain-based assets. Concurrently,… Read More »MEI Pharma Allocates $100 Million to Litecoin Reserves, Appoints Creator Charlie Lee to Board